Transcriptomics

Dataset Information

0

Assessment of tumor pathological and transcriptional biomarkers in pre- and on-treatment core biopsies predictive of response and outcome after neoadjuvant chemotherapy plus Bevacizumab in patients with HER2-negative breast cancer


ABSTRACT: Assessment of tumor pathological and transcriptional biomarkers in pre- and on-treatment core biopsies predictive of response and outcome after neoadjuvant chemotherapy plus Bevacizumab in patients with HER2-negative breast cancer: Results from a multi-center, single-arm, phase 2 study (the PROMIX trial) Global gene expression profiling was performed on samples from 3 time points (baseline, after 2 cycles and surgery) from women with breast cancer receivcing neoadjuvant chemotherapy with bevacizumab in a phase 2 trial

ORGANISM(S): Homo sapiens

PROVIDER: GSE87455 | GEO | 2017/09/01

SECONDARY ACCESSION(S): PRJNA344794

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2018-02-19 | GSE103668 | GEO
| phs001365 | dbGaP
2024-03-19 | PXD039529 | JPOST Repository
2022-01-21 | GSE154524 | GEO
2024-07-01 | GSE207460 | GEO
2016-07-01 | GSE63471 | GEO
2021-12-31 | GSE182951 | GEO
2017-06-30 | E-MTAB-4439 | biostudies-arrayexpress
2016-07-01 | E-GEOD-63471 | biostudies-arrayexpress
2008-12-19 | E-GEOD-4779 | biostudies-arrayexpress